Works matching IS 15674215 AND DT 2022 AND VI 24 AND IP 3

Results: 27
    1
    2
    3
    4
    5

    Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 581, doi. 10.1002/ejhf.2370
    By:
    • Amat-Santos, Ignacio J.;
    • Sánchez-Luna, Juan P.;
    • Abu-Assi, Emad;
    • Melendo-Viu, María;
    • Cruz-Gonzalez, Ignacio;
    • Nombela-Franco, Luis;
    • Muñoz-Garcí, Antonio J.;
    • Blas, Sergio G.;
    • de la TorreHernandez, Jose M.;
    • Romaguera, Rafael;
    • Sánchez-Recalde, Ángel;
    • Diez-Gil, José L.;
    • Lopez-Otero, Diego;
    • Gheorge, Livia;
    • Ibáñez, Borja;
    • Iñiguez-Romo, Andrés;
    • Raposeiras-Roubín, Sergio
    Publication type:
    Article
    6
    7

    Effects of an outpatient intervention comprising nurse-led non-invasive assessments, telemedicine support and remote cardiologists' decisions in patients with heart failure (AMULET study): a randomised controlled trial.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 565, doi. 10.1002/ejhf.2358
    By:
    • Krzesiński, Paweł;
    • Jankowska, Ewa A.;
    • Siebert, Janusz;
    • Galas, Agata;
    • Piotrowicz, Katarzyna;
    • Stańczyk, Adam;
    • Siwołowski, Paweł;
    • Gutknecht, Piotr;
    • Chrom, Paweł;
    • Murawski, Piotr;
    • Walczak, Andrzej;
    • Szalewska, Dominika;
    • Banasiak, Waldemar;
    • Ponikowski, Piotr;
    • Gielerak, Grzegorz
    Publication type:
    Article
    8
    9

    Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
    By:
    • Curtain, James P.;
    • Jackson, Alice M.;
    • Li Shen;
    • Jhund, Pardeep S.;
    • Docherty, Kieran F.;
    • Petrie, Mark C.;
    • Castagno, Davide;
    • Desai, Akshay S.;
    • Rohde, Luis E.;
    • Lefkowitz, Martin P.;
    • Rouleau, Jean-Lucien;
    • Zile, Michael R.;
    • Solomon, Scott D.;
    • Swedberg, Karl;
    • Packer, Milton;
    • McMurray, John J. V.
    Publication type:
    Article
    10
    11

    Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 539, doi. 10.1002/ejhf.2418
    By:
    • Zahir, Deewa;
    • Bonde, Anders;
    • Madelaire, Christian;
    • Malmborg, Morten;
    • Butt, Jawad H.;
    • Fosbol, Emil;
    • Gislason, Gunnar;
    • Torp-Pedersen, Christian;
    • Andersson, Charlotte;
    • Rossignol, Patrick;
    • McMurray, John J. V.;
    • Kober, Lars;
    • Schou, Morten
    Publication type:
    Article
    12
    13
    14

    Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
    By:
    • Butt, Jawad H.;
    • Docherty, Kieran F.;
    • Jhund, Pardeep S.;
    • de Boer, Rudolf A.;
    • Böhm, Michael;
    • Desai, Akshay S.;
    • Howlett, Jonathan G.;
    • Inzucchi, Silvio E.;
    • Kosiborod, Mikhail N.;
    • Martinez, Felipe A.;
    • Nicolau, Jose C.;
    • Petrie, Mark C.;
    • Ponikowski, Piotr;
    • Bengtsson, Olof;
    • Langkilde, Anna Maria;
    • Schou, Morten;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.;
    • Sabatine, Marc S.;
    • McMurray, John J. V.
    Publication type:
    Article
    15
    16

    Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 497, doi. 10.1002/ejhf.2403
    By:
    • Jackson, Alice M.;
    • Rørth, Rasmus;
    • Jiankang Liu;
    • Kristensen, Søren Lund;
    • Anand, Inder S.;
    • Claggett, Brian L.;
    • Cleland, John G. F.;
    • Chopra, Vijay K.;
    • Desai, Akshay S.;
    • Junbo Ge;
    • Jianjian Gong;
    • Lam, Carolyn S. P.;
    • Lefkowitz, Martin P.;
    • Maggioni, Aldo P.;
    • Martinez, Felipe;
    • Packer, Milton;
    • Pfeffer, Marc A.;
    • Pieske, Burkert;
    • Redfield, Margaret M.;
    • Rizkala, Adel R.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 455, doi. 10.1002/ejhf.2395
    By:
    • Ivey-Miranda, Juan B.;
    • Wetterling, Friedrich;
    • Gaul, Robert;
    • Sheridan, Stephen;
    • Asher, Jennifer L.;
    • Rao, Veena S.;
    • Maulion, Christopher;
    • Mahoney, Devin;
    • Mebazaa, Alexandre;
    • Gray, Alastair P.;
    • Burkhoff, Daniel;
    • Cowie, Martin R.;
    • Cox, Zachary L.;
    • Butler, Javed;
    • Fudim, Marat;
    • McDonald, Kenneth;
    • Damman, Kevin;
    • Borlaug, Barry A.;
    • Testani, Jeffrey M.
    Publication type:
    Article
    23
    24

    Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 431, doi. 10.1002/ejhf.2397
    By:
    • Tomasoni, Daniela;
    • Fonarow, Gregg C.;
    • Adamo, Marianna;
    • Anker, Stefan D.;
    • Butler, Javed;
    • Coats, Andrew J. S.;
    • Filippatos, Gerasimos;
    • Greene, Stephen J.;
    • McDonagh, Theresa A.;
    • Ponikowski, Piotr;
    • Rosano, Giuseppe;
    • Seferovic, Petar;
    • Vaduganathan, Muthiah;
    • Voors, Adriaan A.;
    • Metra, Marco
    Publication type:
    Article
    25
    26

    Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 406, doi. 10.1002/ejhf.2414
    By:
    • de Boer, Rudolf A.;
    • Heymans, Stephane;
    • Backs, Johannes;
    • Carrier, Lucie;
    • Coats, Andrew J. S.;
    • Dimmeler, Stefanie;
    • Eschenhagen, Thomas;
    • Filippatos, Gerasimos;
    • Gepstein, Lior;
    • Hulot, Jean-Sebastien;
    • Knöll, Ralph;
    • Kupatt, Christian;
    • Linke, Wolfgang A.;
    • Seidman, Christine E.;
    • Tocchetti, C. Gabriele;
    • van der Velden, Jolanda;
    • Walsh, Roddy;
    • Seferovic, Petar M.;
    • Thum, Thomas
    Publication type:
    Article
    27